Weik Capital Management Has $5.04 Million Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Weik Capital Management decreased its position in UnitedHealth Group Incorporated (NYSE:UNH) by 2.4% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 9,898 shares of the healthcare conglomerate’s stock after selling 240 shares during the period. UnitedHealth Group makes up approximately 2.2% of Weik Capital Management’s holdings, making the stock its 10th biggest position. Weik Capital Management’s holdings in UnitedHealth Group were worth $5,041,000 at the end of the most recent quarter.

A number of other hedge funds also recently made changes to their positions in the business. Bell Investment Advisors Inc increased its holdings in shares of UnitedHealth Group by 4.8% during the fourth quarter. Bell Investment Advisors Inc now owns 525 shares of the healthcare conglomerate’s stock valued at $276,000 after purchasing an additional 24 shares during the period. Harbor Investment Advisory LLC raised its position in shares of UnitedHealth Group by 3.2% during the 1st quarter. Harbor Investment Advisory LLC now owns 35,946 shares of the healthcare conglomerate’s stock worth $17,783,000 after buying an additional 1,129 shares in the last quarter. Austin Private Wealth LLC boosted its holdings in shares of UnitedHealth Group by 9.8% in the first quarter. Austin Private Wealth LLC now owns 1,246 shares of the healthcare conglomerate’s stock valued at $573,000 after acquiring an additional 111 shares in the last quarter. Capital Insight Partners LLC raised its holdings in UnitedHealth Group by 3.8% during the first quarter. Capital Insight Partners LLC now owns 9,045 shares of the healthcare conglomerate’s stock worth $4,475,000 after purchasing an additional 332 shares in the last quarter. Finally, Collective Family Office LLC increased its position in shares of UnitedHealth Group by 4.3% during the 1st quarter. Collective Family Office LLC now owns 1,577 shares of the healthcare conglomerate’s stock valued at $780,000 after purchasing an additional 65 shares during the period. Institutional investors own 87.86% of the company’s stock.

Insider Activity at UnitedHealth Group

In other news, CAO Thomas E. Roos sold 2,851 shares of UnitedHealth Group stock in a transaction that occurred on Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total value of $1,624,727.88. Following the transaction, the chief accounting officer now owns 29,501 shares of the company’s stock, valued at $16,812,029.88. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,500 shares of the firm’s stock in a transaction that occurred on Thursday, July 18th. The stock was sold at an average price of $579.03, for a total value of $868,545.00. Following the sale, the executive vice president now owns 7,785 shares of the company’s stock, valued at approximately $4,507,748.55. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, CAO Thomas E. Roos sold 2,851 shares of the firm’s stock in a transaction on Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the completion of the sale, the chief accounting officer now owns 29,501 shares in the company, valued at approximately $16,812,029.88. The disclosure for this sale can be found here. 0.33% of the stock is owned by company insiders.

UnitedHealth Group Price Performance

Shares of NYSE:UNH opened at $594.32 on Friday. The company has a current ratio of 0.88, a quick ratio of 0.88 and a debt-to-equity ratio of 0.67. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $607.94. The business has a fifty day simple moving average of $569.08 and a 200 day simple moving average of $517.57. The firm has a market cap of $548.81 billion, a price-to-earnings ratio of 36.33, a P/E/G ratio of 1.64 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, July 16th. The healthcare conglomerate reported $6.80 EPS for the quarter, topping analysts’ consensus estimates of $6.66 by $0.14. The firm had revenue of $98.86 billion for the quarter, compared to the consensus estimate of $98.73 billion. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The firm’s revenue was up 6.4% on a year-over-year basis. During the same quarter in the prior year, the company posted $6.14 earnings per share. As a group, sell-side analysts predict that UnitedHealth Group Incorporated will post 27.69 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th will be given a $2.10 dividend. The ex-dividend date is Monday, September 16th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.41%. UnitedHealth Group’s dividend payout ratio is currently 51.34%.

Wall Street Analysts Forecast Growth

A number of research firms recently issued reports on UNH. UBS Group lifted their target price on UnitedHealth Group from $640.00 to $680.00 and gave the stock a “buy” rating in a report on Thursday, July 18th. JPMorgan Chase & Co. increased their target price on shares of UnitedHealth Group from $546.00 to $559.00 and gave the company an “overweight” rating in a research note on Thursday, May 30th. Royal Bank of Canada upped their price target on UnitedHealth Group from $555.00 to $615.00 and gave the company an “outperform” rating in a report on Wednesday, July 17th. Wells Fargo & Company lifted their target price on UnitedHealth Group from $525.00 to $630.00 and gave the stock an “overweight” rating in a report on Wednesday, July 17th. Finally, Jefferies Financial Group raised UnitedHealth Group from a “hold” rating to a “buy” rating and lifted their price target for the stock from $481.00 to $647.00 in a research note on Wednesday, July 17th. Two investment analysts have rated the stock with a hold rating, eighteen have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $614.17.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.